Incidence and Risk Factors for Prosthetic Joint Infection Following TKA

1. High-Yield Summary

• Epidemiologic Baseline and Surgical Burden: Prosthetic joint infection (PJI) occurs in 1.0% to 2.0% of primary total knee arthroplasties (TKA) and escalates to 5.0% to 10.0% following revision procedures, carrying a devastating 5-year all-cause mortality rate exceeding 20% that rivals several common malignancies.
• Host Stratification and Risk Architecture: Risk of infection is dictated by modifiable systemic drivers, particularly poor glycemic control (HbA1c > 7.5% to 8.0%, perioperative glucose > 180 to 200 mg/dL), morbid obesity (BMI > 40 kg/m²), active tobacco abuse, and sarcopenia (odds ratio 2.14). Non-modifiable drivers include inflammatory arthropathies, prior open knee surgeries, and a history of native septic arthritis (pooled secondary PJI incidence of 5.8%, with failure risk highest if the quiescent interval is under 12 months).
• Diagnostic Benchmarks: Serum C-reactive protein (CRP > 10 mg/L) and erythrocyte sedimentation rate (ESR > 30 mm/h) serve as primary screening tests. Definitive diagnosis requires image-guided arthrocentesis performed after a minimum 2-week antimicrobial holiday. Synovial fluid cutoffs for chronic PJI are white blood cell count > 1,700 to 3,000 cells/µL and > 70% to 80% polymorphonuclear neutrophils (PMNs), whereas acute postoperative presentations (< 6 weeks) require thresholds of > 10,000 cells/µL and > 90% PMNs. Synovial alpha-defensin and leukocyte esterase provide rapid, highly sensitive confirmatory adjunctive data.
• Critical Treatment Window: Debridement, Antibiotics, and Implant Retention (DAIR) with mandatory modular component exchange is reserved strictly for acute postoperative infections (≤ 3 to 4 weeks from index surgery) or acute hematogenous seeding (≤ 3 weeks of symptoms) with well-fixed components and intact soft tissues. Chronic PJI characterized by mature sessile biofilms requires complete implant and cement removal, with two-stage exchange arthroplasty using high-dose antibiotic-loaded polymethylmethacrylate (ALAC) spacers remaining the gold standard for durable microbial eradication (85% to 95% success).

2. Anatomy

Vascular Supply to the Extensor Mechanism and Soft-Tissue Envelope

The anterior soft-tissue envelope of the knee relies on a delicate, redundant anastomotic network known as the peripatellar genicular ring. This vascular circle is formed by six major arterial branches: the superior medial and superior lateral genicular arteries, the inferior medial and inferior lateral genicular arteries, the descending genicular artery (originating from the superficial femoral artery), and the anterior tibial recurrent artery. During a standard medial parapatellar arthrotomy, the medial genicular supply to the patella and anteromedial capsule is routinely sacrificed. Consequently, perfusion of the patella and patellar tendon becomes almost entirely dependent on the lateral superior and inferior genicular vessels. Overzealous lateral retinacular release performed to correct patellar maltracking disrupts these remaining lateral conduits, inducing patellar ischemia, osteonecrosis, stress fracture, or catastrophic avulsion of the patellar tendon.

Periprosthetic Dead Space and Capsular Compartments

The knee joint capsule encompasses several distinct anatomical recesses that represent clinical reservoirs for hematoma accumulation and bacterial seeding:

• Suprapatellar Pouch: Extends 4 to 6 cm proximal to the superior pole of the patella, deep to the quadriceps tendon and anterior to the distal femoral shaft. Postoperative hematoma or synovial proliferation in this compartment creates substantial dead space that fosters sessile biofilm expansion.
• Medial and Lateral Gutters: Flank the femoral condyles and provide potential spaces for dependent fluid pooling, especially when capsular closure is incomplete or drains are omitted in high-risk patients.
• Posterior Condylar Capsular Recesses: Situated posterior to the posterior femoral condyles and behind the tibial insert. Incomplete debridement of this posterior compartment during revision or DAIR leaves unaddressed biofilm colonies adjacent to the posterior cruciate ligament stump and popliteal hiatus.

Internervous Planes and Neurovascular Danger Zones

The standard medial parapatellar exposure splits the quadriceps tendon longitudinally, leaves a 3 to 5 mm cuff of tendon on the vastus medialis obliquus (VMO) for repair, and continues distal to the tibial tubercle. This approach traverses an internervous interval between the femoral nerve motor branches innervating the vastus medialis proximally and the saphenous nerve distribution medially.

Several critical neurovascular structures are vulnerable during operative debridement and revision reconstruction:

• Popliteal Neurovascular Bundle: The popliteal artery, vein, and tibial nerve lie directly posterior to the posterior capsule, separated only by the oblique popliteal ligament and thin pericapsular fat. At the level of the joint line, the popliteal artery is positioned slightly lateral to the midline and is held in close proximity to the posterior tibial cortex. Flexing the knee to 90 degrees allows the neurovascular structures to fall posteriorly away from the tibial rim. Uncontrolled plunging of oscillating saws, osteotomes, or posterior retractors during femoral or tibial component explantation can result in transection, pseudoaneurysm, or limb-threatening acute ischemia.
• Common Peroneal Nerve: Courses around the fibular neck posterolaterally, deep to the peroneus longus. The nerve is at risk during extensive posterolateral capsular releases, aggressive posterolateral spacer placement, or prolonged traction during correction of severe fixed valgus and external rotation contractures.
• Infrapatellar Branch of the Saphenous Nerve: Traverses transversely across the anteromedial proximal tibia. Incisions that curve acutely medially across the tibial crest routinely sever this sensory branch, leading to anterolateral numbness or painful traumatic neuroma formation.

3. Pathogenesis

Biofilm Architecture and Phenotypic Transition

The hallmark of prosthetic joint infection is the development of a complex, structured microbial community encapsulated within a protective extracellular matrix, known as a sessile biofilm. Biofilm ontogeny progresses through well-defined chronological stages:

• Reversible Initial Attachment: Within seconds to minutes of bacterial introduction, free-floating planktonic bacteria encounter the prosthetic surface. Initial interaction is driven by non-specific physical forces, including van der Waals forces, electrostatic interactions, and hydrophobic bonding.
• Irreversible Adhesion: Once in proximity, bacteria utilize specialized cell-wall anchored proteins termed Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs). These adhesins bind tenaciously to host proteins that coat the foreign implant surface, including fibronectin, fibrinogen, collagen, and vitronectin.
• Extracellular Polymeric Substance (EPS) Synthesis: Following stable attachment, bacteria downregulate motility genes and synthesize an expansive extracellular polymeric matrix composed of polysaccharide intercellular adhesin (PIA), extracellular DNA (eDNA), proteins, and amyloid fibers. This glycocalyx slime acts as a mechanical shield against host neutrophils, macrophages, antibodies, and complement proteins.
• Maturation and Persister Formation: The biofilm matures into three-dimensional tower- and mushroom-shaped microcolonies traversed by fluid channels that facilitate nutrient exchange. Within these deeper hypoxic and nutrient-depleted zones, bacteria undergo a phenotypic shift into a dormant, metabolically quiescent state known as persister cells or small colony variants (SCVs). These persisters downregulate cell-wall synthesis, rendering standard cell-wall active antimicrobials (such as beta-lactams and vancomycin) completely ineffective, requiring antibiotic concentrations up to 1,000-fold higher than the minimum inhibitory concentration (MIC) of planktonic forms.
• Quorum Sensing and Planktonic Dispersal: Cell density-dependent signaling systems (quorum sensing, such as the agr locus in Staphylococcus aureus) regulate matrix-degrading enzymes. Mature biofilms periodically release planktonic bacteria into the joint cavity, producing acute clinical flare-ups, purulent effusions, and bacteremia.

Biomaterial Interactions and Substrate Specificity

Bacterial colonization dynamics differ markedly depending on implant substrate characteristics. Metallic components manufactured from cobalt-chromium-molybdenum (CoCrMo) and titanium-aluminum-vanadium (Ti-6Al-4V) alloys rapidly adsorb host plasma proteins upon exposure to blood. Ultra-high-molecular-weight polyethylene (UHMWPE) bearings provide a hydrophobic, porous surface that promotes rapid bacterial colonization and robust biofilm adherence. Polyethylene wear debris triggers chronic macrophagic activation, generating tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), and receptor activator of nuclear factor kappa-B ligand (RANKL). This cytokine storm drives periprosthetic osteolysis, destabilizing the bone-cement interface and creating vast unvascularized bone voids that harbor occult bacterial colonies.

Microbiology and Inoculation Routes

The microbial etiology of TKA PJI encompasses a wide spectrum of virulent and indolent pathogens:

• Gram-Positive Staphylococci: Account for 60% to 70% of all cases. Staphylococcus aureus (both methicillin-sensitive [MSSA] and methicillin-resistant [MRSA]) presents with aggressive tissue necrosis, purulent effusions, and rapid bone destruction. Coagulase-negative staphylococci, predominantly Staphylococcus epidermidis and Staphylococcus lugdunensis, are classic producers of extensive slime matrices responsible for subacute or chronic low-grade loosening.
• Streptococcal and Enterococcal Species: Streptococcus agalactiae (Group B), Streptococcus pneumoniae, and viridans group streptococci (9% to 10%) typically present as acute hematogenous infections. Enterococcus faecalis and Enterococcus faecium (3% to 7%) present significant therapeutic challenges due to intrinsic and acquired multidrug resistance.
• Gram-Negative Bacilli: Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis (6% to 10%) occur frequently in elderly hosts with urologic comorbidities, chronic decubitus ulcers, or following prolonged intensive care admissions.
• Indolent Anaerobes and Fastidious Organisms: Cutibacterium acnes and Finegoldia magna represent slow-growing anaerobes that require prolonged incubation (up to 14 days) and often masquerade as aseptic mechanical failure.
• Polymicrobial and Culture-Negative Infections: Polymicrobial infections (10% to 15%) occur in the setting of chronic draining sinuses or wound breakdown. Culture-negative PJI (up to 10% to 20%) is predominantly caused by prior empirical antimicrobial administration, low-inoculum biofilm phenotypes, or unculturable organisms.

Inoculation occurs via three distinct pathways: direct intraoperative contamination (operating room air, skin flora, surgical gloves, instruments), contiguous extension (wound dehiscence, superficial surgical site necrosis, postoperative hematoma), and late hematogenous seeding originating from distant foci (dental abscesses, bacteremia from urinary tract infections, pneumonia, or central venous catheters).

4. Natural History

Untreated Clinical Course

In the absence of aggressive surgical intervention, periprosthetic knee infection progresses relentlessly. The ongoing inflammatory response produces extensive synovial hypertrophy, joint effusion, and capsular stretching. Planktonic bacterial seeding and osteoclast activation lead to rapid endosteal scalloping, trabecular destruction, and loss of supporting metaphyseal bone. As bone-cement or bone-implant interlocks fail, the components loosen, tilt, and subside, generating gross mechanical instability and severe pain. The expanding purulent exudate decompresses along paths of least resistance, rupturing through the anterior arthrotomy and skin envelope to establish a chronic cutaneous sinus tract. Left unchecked, chronic PJI precipitates extensor mechanism disruption, systemic sepsis, profound cachexia, limb loss through above-knee amputation, or patient mortality.

Epidemiology and Incidence Rates

The incidence of PJI following primary elective total knee arthroplasty in contemporary registry cohorts ranges between 1.0% and 2.0% within the first two postoperative years. For revision TKA, the infection rate escalates substantially to 5.0% to 10.0%, reflecting prolonged surgical duration, scarred soft tissues, devascularized bone beds, and compromised local immune defenses. Large-scale propensity-matched national registry data, such as that reported by Liddle et al. from the National Joint Registry for England and Wales, confirm that total knee replacement carries a significantly higher burden of deep infection and 30-day mortality compared to unicompartmental knee replacement.

Risk Stratification: Modifiable vs. Non-Modifiable Determinants

Preoperative patient optimization demands rigorous categorization of systemic and local factors:

Modifiable Risk Factors:

• Glycemic Dysregulation: Preoperative hemoglobin A1c (HbA1c) > 7.5% to 8.0% and perioperative blood glucose spikes > 180 to 200 mg/dL severely impair neutrophil chemotaxis, phagocytosis, and intracellular oxidative killing, tripling the risk of postoperative infection. Elective reconstruction should be deferred until glycemic control is stabilized.
• Morbid Obesity: Body mass index (BMI) > 40 kg/m² is associated with an odds ratio of 2.0 to 3.0 for PJI. Pathophysiologic mechanisms include extensive subcutaneous adipose tissue with poor microvascular perfusion, prolonged operative times, persistent wound drainage, and dead space formation.
• Sarcopenia and Nutritional Depletion: Meta-analytic evidence by Sumbal et al. demonstrates that sarcopenia is an independent predictor of PJI (odds ratio 2.14), wound complications, and 90-day readmission. Serum albumin < 3.5 g/dL, prealbumin < 15 mg/dL, and total lymphocyte count < 1,500 cells/µL signal severe protein-calorie malnutrition that impairs soft-tissue collagen synthesis and wound healing.
• Active Tobacco and Nicotine Use: Nicotine induces peripheral vasoconstriction, microvascular thrombosis, and cellular hypoxia, impairing epithelialization and collagen deposition. Patients should cease all nicotine products for a minimum of 4 to 6 weeks prior to elective arthroplasty.
• Staphylococcus Aureus Colonization: Asymptomatic anterior nares colonization with MSSA or MRSA substantially elevates surgical site contamination risk. Preoperative screening and targeted decolonization protocols using intranasal mupirocin ointment combined with chlorhexidine gluconate skin washes dramatically decrease SSI and PJI rates.
• Remote Infectious Foci: Active periodontal disease, asymptomatic bacteriuria, and chronic skin ulcers must be fully eradicated before proceeding with elective arthroplasty.

Non-Modifiable and Surgical Risk Factors:

• History of Native Joint Septic Arthritis: As demonstrated by Sanka et al., prior native joint septic arthritis confers an alarming pooled secondary PJI incidence of 5.8% (odds ratio 3.2). Arthroplasty performed within a quiescent period of less than 12 months following native infection carries the highest recurrence rates, mandating extensive preoperative aspiration and intraoperative frozen section evaluation.
• Systemic Inflammatory Arthropathies: Patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis experience an elevated risk of PJI (odds ratio 1.8 to 2.2), compounded by long-term immunosuppressive regimens (methotrexate, anti-TNF biologics, Janus kinase inhibitors, corticosteroids).
• Chronic Kidney Disease and Dialysis: End-stage renal disease (ESRD) induces uremic platelet dysfunction, chronic systemic inflammation, and cellular immune senescence, predisposing patients to recurrent bacteremic seeding.
• Perioperative Wound Drainage and Hematoma: Berbari et al. identified persistent wound drainage lasting beyond 72 hours and periprosthetic hematoma formation as potent independent risk factors (odds ratio 3.1) for deep infection.
• Surgical Variables: Operative duration exceeding 90 to 120 minutes, bilateral simultaneous TKA, excessive electrocautery tissue necrosis, and unaddressed surgical dead space significantly elevate infection hazards.

5. Clinical Presentation

History

The clinical presentation of TKA PJI varies along a spectrum from fulminant septic decompensation to insidious, low-grade discomfort:

• Pain Profile and Chronology: In acute postoperative or hematogenous PJI, patients report a sudden, explosive onset of severe resting knee pain, joint distension, and inability to bear weight. In chronic PJI caused by low-virulence organisms, the patient frequently describes a joint that never felt right following the index procedure, characterized by constant dull ache, progressive stiffness, and pain with startup or weight-bearing.
• Surgical History and Wound Complications: Clinicians must elicit details regarding the index hospital stay, including delayed wound healing, wound drainage lasting longer than 72 hours, hematoma formation, superficial dehiscence, or empirical antibiotic prescriptions administered in the early postoperative period without prior joint aspiration.
• Systemic Manifestations: Chills, diaphoresis, and spiking fevers occur in fewer than 30% of chronic PJI cases. The absence of systemic fever must never be interpreted as evidence against deep prosthetic infection.

Physical Examination

Physical examination must be executed in a methodical manner, assessing both local and systemic signs:

• Sinus Tract Identification: Direct visual inspection demonstrating a cutaneous sinus tract communicating directly with the prosthesis or joint space is a major diagnostic criterion [Sensitivity 20% to 30%, Specificity 100%].
• Persistent Wound Drainage: Active serosanguinous or purulent wound discharge persisting beyond 72 hours postoperatively represents deep infection until proven otherwise [Sensitivity 65% to 75%, Specificity 85% to 92%].
• Palpable Knee Effusion (Patellar Tap / Ballotment Test): With the knee in full extension, the examiner compresses the suprapatellar pouch distally with one hand while tapping the patella against the femoral trochlea with the other. A buoyant, rebounding patella confirms a tense joint effusion [Sensitivity 82% to 88%, Specificity 68% to 74%].
• Local Cutaneous Calor Differential: Assessment of skin temperature comparing the operative knee to the contralateral unoperated knee using the dorsum of the hand. A persistent focal temperature increase of > 1.5°C indicates ongoing local inflammation [Sensitivity 78% to 84%, Specificity 72% to 80%].
• Restricted Arc of Motion: Inability to achieve terminal extension, loss of flexion, or severe guarding pain at the extremes of passive motion [Sensitivity 70% to 75%, Specificity 62% to 68%].
• Extensor Mechanism Continuity: Active straight leg raise against gravity to evaluate the functional integrity of the quadriceps tendon, patella, and patellar tendon.

6. Imaging and Diagnostic Studies

Plain Radiography

Initial imaging begins with standard plain radiographs: weight-bearing anteroposterior (AP), true lateral, 30-degree Merchant patellar axial, and full-length hip-to-ankle alignment views. Comparison with immediate postoperative baseline films is paramount.

• Radiolucent Lines and Interface Progression: Progressive radiolucent lines > 2 mm at the bone-cement or bone-implant interface, particularly in previously uninvolved zones, strongly suggest infection.
• Focal Endosteal Scalloping: Rapid, patchy cortical endosteal resorption and osteolysis without extensive polyethylene wear debris suggest septic osteolysis.
• Periosteal Reaction: Lamellar or aggressive periosteal new bone formation along the distal femoral or proximal tibial cortex is highly specific for chronic deep infection.
• Component Loosening and Migration: Frank component subsidence, change in tibial tray tilt > 2 degrees, or femoral component flexion indicate mechanical failure secondary to septic bone loss.

Serologic Biomarkers

Serologic evaluation forms the first-line screening tier in every suspected PJI:

• C-Reactive Protein (CRP): Acute-phase reactant synthesized by hepatocytes. In an uncomplicated TKA, serum CRP peaks on postoperative day 2 to 3 and normalizes by 3 to 6 weeks. A secondary rise or persistent elevation beyond 4 weeks (> 10 mg/L in chronic settings; > 100 mg/L in acute postoperative settings) is highly sensitive for infection [Sensitivity 88% to 94%, Specificity 74% to 86%].
• Erythrocyte Sedimentation Rate (ESR): Reflects fibrinogen-induced red cell rouleaux formation. Normalizes slowly, often remaining elevated for 3 to 6 months postoperatively. A chronic threshold of > 30 mm/h contributes to diagnostic scoring [Sensitivity 75% to 88%, Specificity 68% to 78%].
• Serum D-dimer: Reflects fibrinolysis associated with periprosthetic bacterial biofilm activation. A threshold of > 860 ng/mL demonstrates high diagnostic utility, provided systemic venous thromboembolism, hematoma, or recent surgery are accounted for [Sensitivity 85% to 90%, Specificity 88% to 92%].

Arthrocentesis and Synovial Fluid Analysis (Gold Standard)

Joint aspiration is the single most critical diagnostic procedure. Aspiration must be executed under strict aseptic conditions. Critically, antibiotics must be withheld for a minimum of 2 weeks prior to aspiration to avoid false-negative synovial fluid cultures.

• Synovial White Blood Cell (WBC) Count and Differential: Thresholds vary dramatically depending on the postoperative timing:
  • Chronic PJI (> 6 weeks from index surgery): Synovial WBC > 1,700 to 3,000 cells/µL and > 70% to 80% polymorphonuclear neutrophils (PMNs) [Sensitivity 90% to 96%, Specificity 88% to 95%].
  • Acute Postoperative PJI (< 6 weeks) or Acute Hematogenous PJI: Synovial WBC > 10,000 cells/µL and > 90% PMNs [Sensitivity 85% to 92%, Specificity 86% to 90%].
• Synovial Alpha-Defensin: An antimicrobial peptide released by neutrophils in response to bacterial pathogens. Available as a laboratory immunoassay (ELISA) or rapid lateral flow test. Demonstrates extraordinary diagnostic accuracy that remains unaffected by prior oral or intravenous antimicrobial administration [Sensitivity 95% to 97%, Specificity 96% to 98%].
• Synovial Leukocyte Esterase (LE): Colorimetric enzymatic strip test detecting neutrophil esterase activity. Graded as negative, trace, 1+, or 2+. A 2+ reading is strongly diagnostic of PJI [Sensitivity 85% to 93%, Specificity 88% to 96%]. Centrifugation of bloody aspirates is required to eliminate visual interference from lysed erythrocytes.
• Microbiological Culture Protocol: Synovial fluid should be directly inoculated into pediatric or adult blood culture bottles at the bedside to maximize microbial recovery. Cultures must include aerobic, anaerobic, and fungal media, with extended incubation maintained for 14 days to capture indolent pathogens such as Cutibacterium acnes.

7. Classification

Standardized classifications guide treatment selection by stratifying timing, microbial virulence, and host physiologic reserve.

Tsukayama Classification of Periprosthetic Joint Infection

2018 International Consensus Meeting (ICM) Diagnostic Criteria

McPherson Host and Extremity Staging System

8. Treatment

Medical and Nonoperative Management

Nonoperative treatment alone is non-curative and must be considered solely as palliative suppression. It is reserved for patients who are medically unfit for surgical intervention due to prohibitive perioperative mortality risks, bedridden patients with minimal functional demands, or individuals who refuse component explantation. Chronic antibiotic suppression is indicated only if the following strict prerequisites are met: the prosthetic components are radiographically and clinically well-fixed, the pathogen has been identified with proven susceptibility to well-tolerated oral antimicrobials with low toxicity profiles, and there is no evidence of soft-tissue breakdown or systemic bacteremia. Regimens often utilize oral agents such as cephalexin, doxycycline, amoxicillin, or trimethoprim-sulfamethoxazole. Suppressive therapy carries a 30% to 50% breakthrough failure rate within 2 years and demands regular surveillance of hematologic, renal, and hepatic function.

Operative Modalities

The primary goals of operative management are complete eradication of microbial biofilm, relief of intractable pain, restoration of a functional and stable knee articulation, and durable long-term reconstructive survivorship.

Debridement, Antibiotics, and Implant Retention (DAIR) with Modular Exchange:

• Indications: Strictly indicated for acute postoperative PJI (≤ 3 to 4 weeks from index surgery) or acute hematogenous PJI with symptom duration ≤ 3 weeks, occurring in the presence of firmly fixed components, an intact soft-tissue envelope, and absence of multidrug-resistant or fungal organisms.
• Surgical Technique: The previous surgical incision is reopened, extending through the deep fascia. Radical synovectomy and debridement of all inflamed pseudocapsule are performed. The modular polyethylene insert is removed and discarded; retention of the polyethylene insert is a major technical failure that prevents access to the posterior condylar recesses, intercondylar notch, and popliteal hiatus. The anterior, medial, lateral, and posterior compartments are debrided down to healthy, bleeding tissue. Copious pulsatile lavage with a minimum of 6 to 9 liters of normal saline (often supplemented with dilute povidone-iodine 0.3% soaks for 3 minutes) is administered. The stability of the femoral and tibial trays is verified mechanically. New instruments, gloves, and drapes are utilized before trial reduction and insertion of a fresh, properly sized polyethylene liner. Layered, watertight arthrotomy closure over closed suction drains completes the procedure.

Two-Stage Exchange Arthroplasty (The Gold Standard):

• First Stage (Explantation and Spacer Insertion): All existing components (femoral, tibial, and patellar) and every residual fragment of bone cement, foreign debris, and fibrous membrane are systematically excised using flexible osteotomes, ultrasonic cement removal tools, and high-speed burrs. Five to six distinct periprosthetic tissue biopsy specimens are harvested from the pseudocapsule, synovium, and component-bone interfaces for microbiological and histological analysis. Aggressive debridement of all necrotic bone and synovial tissue is executed. An antibiotic-loaded polymethylmethacrylate (ALAC) spacer is fashioned and implanted:
  • Articulating Spacer: Constructed using commercial silicone or metal molds, or prefabricated antibiotic-impregnated cement components. The articulating spacer preserves joint motion (0 to 90 degrees), prevents quadriceps shortening and extensor mechanism contracture, maintains soft-tissue collateral ligament tension, and significantly facilitates surgical exposure during the second stage.
  • Static Spacer: A solid block of antibiotic cement placed across the joint. Indicated when massive metaphyseal bone loss (AORI Type 3) precludes articulating stability, in the setting of catastrophic extensor mechanism rupture, or when severe ligamentous compromise exists.
  • Antibiotic Dosing in Cement: High-dose, heat-stable dual antimicrobials are incorporated into the polymethylmethacrylate (typically 3.0 to 4.0 g of vancomycin plus 3.6 to 4.8 g of tobramycin per 40 g batch of cement) to ensure bactericidal local elution without compromising structural integrity.
• Interim Antimicrobial Phase: Patients undergo 6 to 12 weeks of targeted pathogen-specific intravenous or high-bioavailability oral antimicrobial therapy under the supervision of Infectious Disease specialists. Following completion of antibiotics, a 2- to 4-week antimicrobial holiday is enforced, during which clinical wound healing, serum ESR, and serum CRP are monitored.
• Second Stage (Reimplantation): Repeat arthrocentesis or intraoperative frozen section confirms biological quiescence. The antibiotic spacer is carefully explanted. Repeat radical debridement and tissue sampling are conducted. Reconstruction is performed using revision TKA implants, typically utilizing semi-constrained condylar knee (CCK) or rotating-hinge designs, supplemented with modular intramedullary stems and porous tantalum or titanium metaphyseal sleeves or cones to address bone defects. Components are secured using low-dose prophylactic antibiotic bone cement.

One-Stage (Single-Stage) Exchange Arthroplasty:

Explantation, debridement, and immediate reimplantation of new revision components in a single operative session. This approach requires strict inclusion criteria: preoperatively identified organism with documented high susceptibility to oral antimicrobials, non-resistant pathogens (avoiding MRSA, vancomycin-resistant enterococci, and fungi), pristine soft-tissue envelope without sinus tract formation, minimal bone loss (AORI Type 1 or 2), and an uncompromised host (McPherson Host A or B). Advantages include a single operative insult, shorter hospitalization, lower aggregate cost, and avoidance of spacer-related morbidity.

Surgical Salvage Procedures:

• Knee Arthrodesis: Indicated for recurrent, intractable PJI failing multiple revision attempts, catastrophic disruption of the extensor mechanism, massive bone loss precluding implant stability, or poor soft-tissue coverage. Arthrodesis can be achieved via a modular, fluted intramedullary arthrodesis nail (fusion rates 80% to 90%) or an external circular ring fixator (e.g., Ilizarov or Taylor Spatial Frame), the latter preferred in the presence of active soft-tissue suppuration or acute infection.
• Above-Knee Amputation (AKA): The ultimate surgical salvage reserved for patients with persistent, life-threatening systemic sepsis, intractable deep infection unresponsive to debridement, catastrophic soft-tissue necrosis with major neurovascular injury, or severe local bone loss incompatible with structural reconstruction.

Indications & Contraindications

Surgical decision-making hinges on definitive chronological and anatomical parameters:

• DAIR: Strictly indicated for symptom duration ≤ 21 to 28 days, well-fixed implants, intact soft tissues. Absolute contraindications: symptom duration > 4 weeks, loose components, presence of a cutaneous sinus tract, or multi-drug resistant/fungal pathogens.
• Two-Stage Exchange: Indicated for all chronic PJI (> 4 weeks), loose implants, unknown or multidrug-resistant organisms, compromised soft tissues, and failed prior DAIR.
• Reimplantation Thresholds: Resolution of clinical signs of inflammation, completely healed wound, downtrending serum CRP (< 10 mg/L) and ESR, and intraoperative frozen section showing < 5 PMNs per high-power field across at least 5 fields.

9. Outcome

Infection Eradication Rates Across Surgical Modalities

The efficacy of surgical intervention is determined by biofilm maturity, pathogen virulence, and host physiologic reserve:

• DAIR Success Rates: Overall success in eradicating infection ranges from 50% to 70%. When executed within 7 days of acute symptom onset in an uncompromised host infected with drug-susceptible streptococci, success rates exceed 80%. Conversely, if performed beyond 3 to 4 weeks or in the presence of MRSA, enterococcal species, or gram-negative bacilli, success plummets below 30% to 40%. Failure of DAIR significantly increases subsequent failure rates of two-stage exchange.
• Two-Stage Exchange Arthroplasty: Remains the most reliable intervention, consistently delivering infection eradication rates between 85% and 95% at 5-year follow-up across multinational registries. Reinfection risk is elevated in patients with Host C status, morbid obesity, prior failed revisions, and resistant organisms.
• One-Stage Exchange Arthroplasty: In rigorously selected cohorts with known, highly susceptible organisms and pristine soft-tissue envelopes, single-stage revision achieves infection control rates of 85% to 90%, comparable to two-stage protocols.

Functional Scores and Patient-Reported Outcomes

While infection eradication is the primary surgical objective, functional restoration is frequently compromised compared to primary TKA. Knee Society Scores (KSS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores improve significantly following successful two-stage revision, but average final flexion remains between 95 and 105 degrees. Patients managed with articulating spacers demonstrate superior postoperative range of motion (mean 102 degrees vs. 88 degrees), reduced extensor lag, and higher subjective satisfaction scores compared to patients treated with static spacers.

Long-Term Survivorship and Mortality

Ten-year mechanical survivorship of revision TKA constructs following successful two-stage infection eradication ranges from 75% to 85%, with secondary aseptic loosening, progressive metaphyseal bone resorption, and recurrent PJI representing the predominant failure modes. The 5-year all-cause mortality following TKA PJI is estimated at 21% to 25%, a sobering statistic that highlights the systemic frailty and substantial metabolic burden carried by this patient cohort.

10. Complications

11. Pearls and Pitfalls

Expert Surgical Pearls

• The Mandatory 2-Week Antibiotic Holiday: Never aspirate a suspected knee or initiate empirical oral or intravenous antimicrobials until at least 14 days have elapsed following cessation of prior antibiotics. Prior antimicrobial administration suppresses microbial growth, converts aspirate cultures to false negatives, and delays pathogen-directed therapy.
• Standardized Intraoperative Biopsy Protocol: During surgical exploration, harvest 5 to 6 distinct tissue specimens from the pseudocapsule, synovium, and component interfaces using separate, clean rongeurs and scalpel blades for each sample. Never submit superficial wound swabs, sinus tract tracts, or joint fluid alone, as these isolate skin contaminants and yield unrepresentative data.
• Non-Negotiable Modular Component Exchange: In any DAIR procedure, modular polyethylene exchange is mandatory. Removing the insert provides access to the posterior condylar recesses, popliteal hiatus, and intercondylar notch, permitting radical posterior debridement. Failure to remove the liner decreases DAIR success rates by more than 30%.
• Spacer Gap Balancing and Mechanics: When fashioning an articulating spacer, meticulously match the flexion and extension gaps. An undersized spacer induces ligamentous laxity and joint subluxation, whereas an oversized spacer causes soft-tissue necrosis, excessive skin tension, and quadriceps contracture. Maintaining joint line height prevents patellar tendon shortening (patella baja), greatly facilitating exposure during second-stage reimplantation.

Common Diagnostic and Clinical Pitfalls

• Over-Reliance on Negative Gram Stains: Synovial fluid and tissue Gram stains demonstrate notoriously poor diagnostic sensitivity (frequently below 20% to 30%). Never dismiss suspected infection on the basis of a negative intraoperative Gram stain.
• The “Heroic” DAIR in Chronic PJI: Performing DAIR in a patient whose symptoms exceed 4 weeks, or whose implants exhibit subtle radiographic radiolucencies, is a critical surgical error. Biofilms at this stage are mature and sessile; retaining components leads to near-certain failure, compromises soft-tissue beds, and increases subsequent two-stage revision failure rates.
• Aspirating a Joint with an Antibiotic Spacer in Situ: Joint aspiration while an antibiotic-loaded polymethylmethacrylate spacer is in place generates a high rate of false-negative culture results due to ongoing local antibiotic elution. Timing of second-stage reimplantation must rely on systemic inflammatory kinetics (downtrending ESR and CRP), skin envelope quiescence, and intraoperative frozen sections rather than spacer aspirate cultures.
• Incomplete Cement Removal During Stage One: Leaving behind fragmented polymethylmethacrylate mantles or plugs shields sessile colonies from host immune defenses and systemic antimicrobials. All cement fragments must be completely extracted, using fluoroscopic guidance or high-speed burrs when necessary, to avoid immediate recontamination of the second-stage revision.

12. Controversy

Single-Stage vs. Two-Stage Exchange Arthroplasty

Considerable debate persists regarding the routine adoption of single-stage revision arthroplasty versus the traditional North American gold standard of two-stage exchange. Advocates of single-stage revision, predominantly in European centers, emphasize that complete component removal combined with radical debridement, instantaneous reconstruction, and culture-directed antibiotic-loaded cement achieves infection eradication rates (85% to 90%) comparable to two-stage protocols. This eliminates the morbidity, prolonged hospitalization, extensor mechanism stiffening, and elevated costs associated with temporary cement spacers. Conversely, proponents of two-stage exchange emphasize its broader applicability, highlighting superior reliability in the face of resistant pathogens (MRSA, enterococci), compromised soft-tissue envelopes, unknown pre-culture pathogens, and severely debilitated hosts.

Oral Step-Down Antimicrobial Therapy (The OVIVA Trial Paradigm)

Traditional infectious disease doctrine mandated a minimum of 6 to 12 weeks of continuous intravenous antimicrobial therapy delivered through peripherally inserted central catheters (PICC). This standard has been challenged by the landmark OVIVA (Oral Versus IntraVenous Antibiotics) randomized clinical trial, which demonstrated that an early transition to oral antimicrobial therapy with high bioavailability is non-inferior to prolonged intravenous therapy in complex bone and joint infections. Oral step-down therapy eliminates line-associated complications, including catheter-related bloodstream infections and upper-extremity deep vein thrombosis, substantially reducing healthcare expenditures. Ongoing debate centers on defining which specific pathogens (such as difficult-to-treat gram-negative bacilli or rifampin-resistant staphylococci) still necessitate prolonged intravenous courses.

Dual-Antibiotic Bone Cement in Primary Arthroplasty

The prophylactic addition of dual antibiotics to bone cement (e.g., combinations of erythromycin and colistin, or vancomycin and tobramycin) has been advocated to broaden antimicrobial coverage against resistant hospital flora. However, contemporary high-level randomized evidence by Pardo-Pol et al. evaluated 2,893 knees at a mean 9-year follow-up and demonstrated no reduction in PJI incidence with erythromycin-colistin dual-antibiotic cement compared to standard single-antibiotic cement (1.4% vs. 1.6%). Routine incorporation of dual-antibiotic cement in unselected primary arthroplasties escalates surgical costs and increases the selective pressure for multi-drug resistant organisms without conferring clinical benefit.

Timing and Diagnostics Prior to Second-Stage Reimplantation

No universal clinical consensus exists regarding the definitive criteria that guarantee complete bacterial clearance prior to second-stage reimplantation. Serum inflammatory markers (ESR and CRP) frequently remain mildly elevated following spacer placement due to foreign-body reaction and tissue healing. Repeating joint aspiration during the interim spacer period is controversial, as local antibiotic elution induces false-negative cultures. Emerging techniques, including synovial calprotectin, next-generation sequencing (NGS), and intraoperative frozen section analysis showing fewer than 5 PMNs per high-power field, are increasingly utilized to guide reimplantation timing.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Pardo-Pol A, Fontanellas-Fes A, Pérez-Prieto D et al. The Use of Erythromycin and Colistin Cement in Total Knee Arthroplasty Does Not Reduce the Incidence of Infection: A Randomized Study in 2,893 Knees With a 9-year Average Follow-Up. J Arthroplasty. 2024. doi:10.1016/j.arth.2024.04.039 [Level I: Randomized Controlled Trial]
• Sanka SK, Tahir M, Lakpriya S et al. Total Hip or Knee Arthroplasty in Patients with a History of Native Joint Septic Arthritis: A Meta-analysis and Systematic Review of Risk Factors of Prosthetic Joint Infection. Clin Orthop Surg. 2025. doi:10.4055/cios25102 [Level I: Systematic Review / Meta-Analysis]
• Sumbal R, Abbas M, Sheikh SM et al. Prevalence and Clinical Impact of Sarcopenia in Patients Undergoing Total Joint Arthroplasty: A Systematic Review and a Meta-Analysis. J Arthroplasty. 2024. doi:10.1016/j.arth.2024.06.021 [Level I: Systematic Review / Meta-Analysis]
• Elie F. Berbari, Arlen D. Hanssen, M. C. T. Duffy et al. Risk Factors for Prosthetic Joint Infection: Case‐Control Study. Clinical Infectious Diseases. 1998. doi:10.1086/514991 [Level III: Case-Control Study]
• Thomas W. Wainwright, Mike Gill, David McDonald et al. Consensus statement for perioperative care in total hip replacement and total knee replacement surgery: Enhanced Recovery After Surgery (ERAS ^® ) Society recommendations. Acta Orthopaedica. 2019. doi:10.1080/17453674.2019.1683790 [Level V: Clinical Consensus & Systematic Review]
• Alexander D. Liddle, Andrew Judge, Hemant Pandit et al. Adverse outcomes after total and unicompartmental knee replacement in 101 330 matched patients: a study of data from the National Joint Registry for England and Wales. The Lancet. 2014. doi:10.1016/s0140-6736(14)60419-0 [Level III: Propensity Score-Matched National Registry Cohort Study]

15. Master Class Pro-Tip

When evaluating a patient with persistent wound drainage or early acute erythema following total knee arthroplasty, the most common clinical error is initiating empirical oral antibiotics in the clinic without performing an arthrocentesis. Empirical antibiotics mask diagnostic synovial fluid biomarkers, decrease microbiological culture sensitivity by up to 50%, and convert what could have been a salvageable acute presentation into a recalcitrant, culture-negative chronic biofilm infection. If active wound drainage persists beyond 72 hours postoperatively, immediately aspirate the knee under strict sterile conditions before any antimicrobial administration, sending synovial fluid for cell count, differential, alpha-defensin, and extended 14-day cultures. If DAIR is selected within the acute 3- to 4-week window, modular polyethylene insert exchange is non-negotiable. Never attempt to debride around a retained liner; removing the insert is essential to access the posterior condylar recesses, inspect the implant-cement interfaces for subtle mechanical loosening, and eradicate hidden biofilm reservoirs.

Master Class Surgical Pearl: Prosthetic Joint Infection in Total Knee Arthroplasty